middle.news
PainChek Secures $1.123M R&D Refund to Accelerate US Expansion
8:29am on Wednesday 22nd of July, 2026 AEST
•
Healthcare
Read Story
PainChek Secures $1.123M R&D Refund to Accelerate US Expansion
8:29am on Wednesday 22nd of July, 2026 AEST
Key Points
Received $1.123 million R&D tax refund for FY2025
Funds support PainChek Adult and Infant algorithm development
Validation activities aimed at US market entry and pediatric use
Refund strengthens cash position amid US expansion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Painchek (ASX:PCK)
OPEN ARTICLE